Discover 63 paid clinical trials in Bismarck, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 63
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
for
Peritoneal Malignant Mesothelioma
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05001880
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
for
PTSD - Post Traumatic Stress Disorder,
Location: Bismarck ND, Osceola AR
Sponsor: University of Arkansas
Sex: All
Age: 18+
Code: NCT06923423
Recruiting
Mobile Health for Adherence in Breast Cancer Patients
for
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma,
Location: Bismarck ND, Fargo ND, Thief River Falls MN, Bemidji MN,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06112613
Recruiting
Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study
for
Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Location: Bismarck ND, Fargo ND, Sioux Falls SD, Rice Lake WI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT05863351
Phase3, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Bismarck ND, Fargo ND, Rapid City SD, Bemidji MN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 70+
Code: NCT05564377
Phase2, Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,